You just read:

Viking Therapeutics Announces Initial Results from In Vivo Proof-of-Concept Study of VK2809 in Glycogen Storage Disease Ia (GSD Ia)

News provided by

Viking Therapeutics, Inc.

Feb 09, 2017, 07:03 ET